H1 Antihistamines: Current Status and Future Directions
In this review, we compare and contrast the clinical pharmacology, efficacy, and safety of first-generation H1 antihistamines and second-generation H1 antihistamines. First-generation H1 antihistamines cross the blood-brain barrier, and in usual doses, they potentially cause sedation and impair cogn...
Main Authors: | F. Estelle R. Simon, Keith J. Simons |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-01-01
|
Series: | World Allergy Organization Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455119305915 |
Similar Items
-
Current status of antihistamine drugs repurposing for infectious diseases
by: Bruno L. Travi
Published: (2022-09-01) -
Clinical use of H1-antihistamines
by: A. V. Emelyanov
Published: (2016-12-01) -
CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria
by: Michael N. Fein, et al.
Published: (2019-10-01) -
EFFICACY OF H1 ANTIHISTAMINES IN CHILDREN WITH FOOD ALLERGY
by: I.I. Balabolkin, et al.
Published: (2007-03-01) -
EFFICACY OF H1 ANTIHISTAMINES IN CHILDREN WITH FOOD ALLERGY
by: I.I. Balabolkin, et al.
Published: (2007-01-01)